U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H26N2O.ClH
Molecular Weight 310.862
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE HYDROCHLORIDE

SMILES

Cl.COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1

InChI

InChIKey=QEBJXWFHKCUFLS-UHFFFAOYSA-N
InChI=1S/C17H26N2O.ClH/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17;/h6-7,10-13,18H,8-9H2,1-5H3;1H

HIDE SMILES / InChI

Molecular Formula C17H26N2O
Molecular Weight 274.4011
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
2003 Apr 4
Foxy, a designer tryptamine hallucinogen.
2003 Jul-Aug
[Latest cases of acute poisoning in clinical practice--5MeO-DIPT and GHB precursor].
2004 Jul
Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
2004 Nov
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
2004 Sep
Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
2004 Sep 29
Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry.
2005 Aug 25
Foxy methoxy: a new drug of abuse.
2005 Dec
False positives and false negatives with a cocaine-specific field test and modification of test protocol to reduce false decision.
2005 Dec 20
A foxy intoxication.
2005 Feb 10
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
2006 Apr
Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
2006 Apr 28
Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan.
2006 Dec 20
Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
2006 Feb
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
2006 Jan
A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
2006 Nov 10
[Analysis of the chemical drugs among structural isomer].
2006 Sep
Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan.
2006 Sep 26
Acute confusional state after designer tryptamine abuse.
2007 Apr
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
2007 Apr 5
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
2007 Jun
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
2007 Mar 22
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
2008 Feb
Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.
2008 Feb 1
Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods.
2008 Feb 15
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
2008 Jan
A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation.
2008 Jan 15
Indolealkylamines: biotransformations and potential drug-drug interactions.
2008 Jun
The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
2008 Mar 10
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats.
2008 May 30
Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
2009 Jun
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.
2010 Jun 24
Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.
2010 Mar-Apr
The hallucinogenic world of tryptamines: an updated review.
2015 Aug
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:54:12 GMT 2023
Edited
by admin
on Sat Dec 16 08:54:12 GMT 2023
Record UNII
SJ048VQB9S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE HYDROCHLORIDE
MI  
Systematic Name English
1H-INDOLE-3-ETHANAMINE, 5-METHOXY-N,N-BIS(1-METHYLETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
5-METHOXY-N,N-BIS(1-METHYLETHYL)-1H-INDOLE-3-ETHANAMINE HYDROCHLORIDE
Systematic Name English
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
MERCK INDEX
m7332
Created by admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID7048900
Created by admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
PRIMARY
FDA UNII
SJ048VQB9S
Created by admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
PRIMARY
PUBCHEM
24802109
Created by admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
PRIMARY
CAS
2426-63-3
Created by admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY